BRIDGEND GROUP
MERTHYR MAWR ROAD, BRIDGEND
CHD 14
The percentage of patients with a history of myocardial infarction (from 1 April 2011) currently treated with an ACE inhibitor (or ARB if ACE intolerant), aspirin or an alternative anti-platelet therapy, beta blocker and statin (unless a contraindication or side effects are recorded)
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| CHD 11 | 2005 | 20 | 27 | 74.1% | |
| CHD 11 | 2006 | 26 | 32 | 81.2% | |
| CHD 11 | 2007 | 33 | 38 | 86.8% | |
| CHD 11 | 2008 | 34 | 39 | 87.2% | |
| CHD 11 | 2009 | 36 | 40 | 90.0% | |
| CHD 11 | 2010 | 41 | 46 | 89.1% | |
| CHD 11 | 2011 | 42 | 46 | 91.3% | |
| CHD 14 | 2012 | 4 | 4 | 100.0% | |
| CHD 14 | 2013 | 8 | 9 | 88.9% | |
| CHD006W | 2014 | 15 | 15 | 100.0% | |
| CHD006 | 2015 | 16 | 16 | 100.0% |
